Impact of a Multicomponent Exercise Program on Functional Capacity in Frail Aged Participants With Cognitive Decline
1 other identifier
interventional
240
1 country
1
Brief Summary
Randomized Controlled trial of 370 aged participants over 75 years old coming from clinics of Geriatric Departments in three University Hospitals in Spain (Pamplona, Getafe y San Sebastián). Participants who met inclusion criteria will be randomized to control (usual care)l or intervention group (multicomponent exercise program). The main objective of the trial is to study the effect of a multicomponent exercise training program (resistance, aerobic, strength, balance and flexibility) in frail aged participants who live in the community with cognitive decline in: functional capacity, strength, power, cognition, falls , depression, quality of life, institutionalization and hospital admissions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
July 30, 2018
CompletedFirst Posted
Study publicly available on registry
September 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedSeptember 5, 2018
September 1, 2018
2.2 years
July 30, 2018
September 3, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Short Physical Performance Battery (SPPB)
The functional capacity of patients will be evaluated by the Short Physical Performance Battery (SPPB) which evaluates, balance, gait ability, and leg strength using a single tool. The total score ranges from 0 (worst) to 12 points (best). The SPPB test has been shown to be a valid instrument for screening frailty and predicting disability, institutionalization, and mortality. A total score of less than 10 indicates frailty and a high risk of disability and falls. A one-point change in the score has clinical relevance
Changes from baseline to 1st and 3th months of follow up
Secondary Outcomes (25)
Barthel index
Changes from baseline to 1st and 3th months of follow up
Handgrip strength in the dominant hand
Changes from baseline to 1st and 3th months of follow up
6-metre gait velocity test (GVT).
Changes from baseline to 1st and 3th months of follow up
MEC-Lobo cognitive test
Changes form baseline to 1st and 3th months of follow up
MOCA( Montreal Cognitive Assessment) test
Changes from baseline to 1st and 3th months of follow up
- +20 more secondary outcomes
Other Outcomes (13)
Mini- Nutritional Assessment (MNA)
Baseline visit
Cumulative Illness Rating Scale for Geriatrics (CIRS-G)
Baseline visit
Functional Activities Questionnaire (FAQ)
Changes from baseline to 1st and 3th months follow up
- +10 more other outcomes
Study Arms (2)
Exercise intervention
EXPERIMENTALmulticomponent exercise training program \[VIVIFRAIL\],
Usual Care
NO INTERVENTIONParticipants randomly assigned to the usual care group will receive normal outpatient care, which includes physical rehabilitation when needed.
Interventions
The supervised multicomponent exercise training programme will be comprised of upper and lower body strengthening exercises, tailored to the individual's functional capacity, using dumbbells aiming for 2-3 sets of 10-15 repetitions at an intensity of 30-50% of 1Repetition Maximum ( combined with balance-training, flexibility and gait exercises that progressed in difficulty.
Eligibility Criteria
You may qualify if:
- \- Age: 75 years or older.
- Able to ambulate with or without personal/technical assistance.
- Barthel Index ≥ 60.
- Able to communicate.
- Mild cognitive impairment or Dementia level GDS-4.
- Fragility o pre-frailty according to Linda Fried ≥ 1.
- Subjects should have someone to help them do the exercises.
- Informed consent: Must be capable and willing to provide consent.
You may not qualify if:
- Any factor precluding performance of the physical training programme or testing procedures as determined by the attending physician. These factors include, but are not limited to the following:
- Myocardial infarction in the past 3 months.
- Unstable Angina pectoris.
- Terminal illness.
- Uncontrolled arrhythmia.
- Unstable cardiovascular disease or other medical condition.
- Uncontrolled arterial hypertension.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundacion Miguel Servetlead
- Matia Foundationcollaborator
- Hospital Universitario Getafecollaborator
Study Sites (1)
Fundación Miguel Servet/ Navarrabiomed
Pamplona, 31008, Spain
Related Publications (2)
Casas-Herrero A, Saez de Asteasu ML, Anton-Rodrigo I, Sanchez-Sanchez JL, Montero-Odasso M, Marin-Epelde I, Ramon-Espinoza F, Zambom-Ferraresi F, Petidier-Torregrosa R, Elexpuru-Estomba J, Alvarez-Bustos A, Galbete A, Martinez-Velilla N, Izquierdo M. Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial. J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):884-893. doi: 10.1002/jcsm.12925. Epub 2022 Feb 11.
PMID: 35150086DERIVEDCasas-Herrero A, Anton-Rodrigo I, Zambom-Ferraresi F, Saez de Asteasu ML, Martinez-Velilla N, Elexpuru-Estomba J, Marin-Epelde I, Ramon-Espinoza F, Petidier-Torregrosa R, Sanchez-Sanchez JL, Ibanez B, Izquierdo M. Effect of a multicomponent exercise programme (VIVIFRAIL) on functional capacity in frail community elders with cognitive decline: study protocol for a randomized multicentre control trial. Trials. 2019 Jun 17;20(1):362. doi: 10.1186/s13063-019-3426-0.
PMID: 31208471DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alvaro Casas Herrero, MD PhD
Complejo Hospitalario de Navarra/Fundación Navarrabiomed
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2018
First Posted
September 5, 2018
Study Start
September 1, 2017
Primary Completion
December 1, 2019
Study Completion
March 1, 2020
Last Updated
September 5, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share